Lyell Immunopharma
California, United States
501-1000 Employees
Healthcare
•Tech
Vice President, Process Sciences
Seattle, --
WA Full time
Description
Lyell Immunopharma is a biotechnology company dedicated to advancing the field of cancer immunotherapy. Founded in 2018, the company focuses on developing innovative technologies to engineer T cells for enhanced anti-tumor activity. With a mission to revolutionize cancer treatment, Lyell Immunopharma is at the forefront of creating personalized cell therapies to combat a wide range of cancers.
Financials
Type
public
Annual Revenue
--
Market Cap
$165.1M+
Subscribe to Refer Me premium to get referred to this role at Lyell Immunopharma!
